Drugs / Rosuzet
last change Mar 2026 re-read 2 minutes ago

Rosuzet

Developed for
type 2 diabetes mellitus
Investigated by
Hanmi Pharmaceutical Company Limited · Severance Hospital · Sin Gon Kim · Yuhan Corporation

Trials 1 · a red edge is where a trial was stopped

2027202820292030
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT07359105 Mar 2026 → Dec 2029 expected type 2 diabetes mellitus Sin Gon Kim Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Rosuzet “Treatment will consist of non-pharmacological interventions or marketed medications, including low-dose statins (atorvastatin 5 mg or 10 mg, rosuvastatin 2.5 mg or 5 mg) in...” NCT07359105